I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.

In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

Belma Alispahic, Co-Founder and Chief Scientific Officer of AnalysisMode.

With a Master’s in Applied Biotechnology from Uppsala University and a track record of turning complexity into clarity, Belma is reshaping how we think about bioprocess development.

At AnalysisMode, she leads the charge behind SimCell, an AI-powered platform designed to accelerate bioprocess efficiency, reduce time-to-market, and future-proof pharmaceutical workflows.

Belma recently took the stage at the 9th Bioproduction Congress (BIOPC 2024) in France, where she shared her insights on “Future-Proofing with AI-Powered Bioprocess Development.” Her message was clear: AI isn’t optional—it’s essential for navigating the increasingly complex biopharma landscape.

This isn’t just about algorithms—it’s about empowering scientists to make smarter decisions, faster. Belma’s work is a testament to what happens when deep scientific expertise meets bold technological vision.